When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNSS - Sunesis Pharma down 24% on disappointing vecabrutinib data
Viracta Therapeutics Inc Com
Nano cap Sunesis Pharmaceuticals (SNSS-24.2%) slumps on a 20x surge in volume in apparent response to an abstract on an ongoing Phase 1/2 clinical trial evaluating BTK inhibitor vecabrutinib in patients with B cell blood cancers. The data will be presented at ASH in Sunday, December 8.
More news on: Sunesis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,